Skip to main content

Articles

Page 1 of 16

  1. Evidence suggests people who inject drugs (PWID) prescribed opioid agonist treatment (OAT) are less likely to provide injection drug use (IDU) initiation assistance. We investigated the association between OAT...

    Authors: Stephanie A. Meyers-Pantele, Maria Luisa Mittal, Sonia Jain, Shelly Sun, Indhu Rammohan, Nadia Fairbairn, M-J Milloy, Kora DeBeck, Kanna Hayashi and Dan Werb
    Citation: Substance Abuse Treatment, Prevention, and Policy 2022 17:39
  2. Certificate-of-need (CON) laws in place in most US states require healthcare providers to prove to a state board that their proposed services are necessary in order to be allowed to open or expand. While CON l...

    Authors: James Bailey, Thanh Lu and Patrick Vogt
    Citation: Substance Abuse Treatment, Prevention, and Policy 2022 17:38
  3. International drug policy is rapidly evolving in tandem with promising evidence for psychedelic-assisted psychotherapy (PAP) in treating a range of mental health conditions. Canada is among the countries incre...

    Authors: Victor Mocanu, Lindsay Mackay, Devon Christie and Elena Argento
    Citation: Substance Abuse Treatment, Prevention, and Policy 2022 17:37
  4. Approximately 3.8% of adults worldwide have used cannabis in the past year. Understanding how cannabis use is associated with other health conditions is crucial for healthcare providers seeking to understand t...

    Authors: Howard Padwa, David Huang, Larissa Mooney, Christine E. Grella, Darren Urada, Douglas S. Bell, Brittany Bass and Anne E. Boustead
    Citation: Substance Abuse Treatment, Prevention, and Policy 2022 17:36
  5. It is critical to develop empirically based, community-treatment friendly, psychotherapy interventions to improve treatment for patients with comorbid chronic pain and Opioid Use Disorder. Understanding factor...

    Authors: Amy Wachholtz, Dallas Robinson and Elizabeth Epstein
    Citation: Substance Abuse Treatment, Prevention, and Policy 2022 17:35
  6. Evidence continues to show that young people, ages 15-24, remain at significant risk of harms from non-medical opioid use and opioid use disorder (OUD), with experts calling for widespread implementation of de...

    Authors: Kirsten Marchand, Roxanne Turuba, Christina Katan, Chantal Brasset, Oonagh Fogarty, Corinne Tallon, Jill Fairbank, Steve Mathias and Skye Barbic
    Citation: Substance Abuse Treatment, Prevention, and Policy 2022 17:34
  7. Patterns of movement, heterogeneity of context, and individual space-time patterns affect health, and individuals’ movement throughout the landscape is shaped by addiction, meeting basic needs, and maintaining...

    Authors: Jill Owczarzak, Jessie Chien, Karin Tobin, Alyona Mazhnaya, Olena Chernova and Tetiana Kiriazova
    Citation: Substance Abuse Treatment, Prevention, and Policy 2022 17:33
  8. Although Kazakhstan National Anti-Doping Organization (KazNADO) exists since 2013, but little is yet known about anti-doping (AD) knowledge of Kazakhstan athletes. The aim of this study was to assess the AD educa...

    Authors: Galiya Zhumabayeva, Gulnara Kapanova, Denis Vinnikov, Maira Bakasheva, Venera Abdulla and Andrej Grjibovski
    Citation: Substance Abuse Treatment, Prevention, and Policy 2022 17:32
  9. This study aimed to evaluate the effects of the World Anti-Doping Agency's e-learning programme for anti-doping education on knowledge of, explicit and implicit attitudes towards, and likelihood of doping amon...

    Authors: Zhangyan Deng, Jinyang Guo, Dong Wang, Tao Huang and Zuosong Chen
    Citation: Substance Abuse Treatment, Prevention, and Policy 2022 17:31
  10. Drug-related psychiatric comorbidity or death among adolescents has grown to become a public health threat in Taiwan. In an atmosphere of abstinence, few alternatives or rehabilitative options for troubled you...

    Authors: Lanying Huang
    Citation: Substance Abuse Treatment, Prevention, and Policy 2022 17:30
  11. Tobacco control program leaders and their partners, who often present evidence to policymakers, can increase the use of evidence in program and policy development. However, up-to-date evidence from the scienti...

    Authors: Virginia Mckay, Mia Vogel, Todd Combs, Laura Brossart, Amy Endrizal, Stephanie Andersen, Timothy Poor, Margaret Mahoney and Douglas Luke
    Citation: Substance Abuse Treatment, Prevention, and Policy 2022 17:29
  12. Neurofeedback (NF) has been described as “probably efficacious” when used in conjunction with other interventions for substance use disorders, including the recent studies in the population of individuals with...

    Authors: Helena A. Rempala and Justin A. Barterian
    Citation: Substance Abuse Treatment, Prevention, and Policy 2022 17:28
  13. Methamphetamine use in men who have sex with men population is significantly higher than that in the general population. Meth use can cause high-risk sexual behaviors, such as having sex with a variety of sexu...

    Authors: Salah Moradi, Yousef Moradi, Khaled Rahmani, Bijan Nouri and Ghobad Moradi
    Citation: Substance Abuse Treatment, Prevention, and Policy 2022 17:27
  14. Drug overdose deaths in the United States have continued to increase at an alarming rate. The Substance Abuse and Mental Health Services Administration (SAMHSA) distributed more than $7 billion between January...

    Authors: David L.Driscoll, Alison Evans Cuellar, Vinod Agarwal, Debra Jones, Mary Beth Dunkenberger and Kathy Hosig
    Citation: Substance Abuse Treatment, Prevention, and Policy 2022 17:26
  15. The British Columbia (BC) Take-Home Naloxone (THN) program provides naloxone to people at risk of experiencing or witnessing an opioid overdose for use in reversing suspected overdose events. This study seeks ...

    Authors: Victor Lei, Max Ferguson, Rachael Geiger, Sierra Williams, Lisa Liu and Jane A. Buxton
    Citation: Substance Abuse Treatment, Prevention, and Policy 2022 17:25
  16. This meta-ethnography investigates how young adults describe their tobacco use, smoking identities and pathways into and out of regular smoking, to inform future smoking prevention and harm reduction intervent...

    Authors: Ria Poole, Hannah Carver, Despina Anagnostou, Adrian Edwards, Graham Moore, Pamela Smith, Fiona Wood and Kate Brain
    Citation: Substance Abuse Treatment, Prevention, and Policy 2022 17:24
  17. People who inject drugs (PWID) in Georgia have a high prevalence of hepatitis C virus antibody (anti-HCV). Access to care among PWID could be prioritized to meet the country’s hepatitis C elimination goals. Th...

    Authors: Maia Butsashvili, Tinatin Abzianidze, George Kamkamidze, Lasha Gulbiani, Lia Gvinjilia, Tinatin Kuchuloria, Irina Tskhomelidze, Maka Gogia, Maia Tsereteli, Veronique Miollany, Tamar Kikvidze, Shaun Shadaker, Muazzam Nasrullah and Francisco Averhoff
    Citation: Substance Abuse Treatment, Prevention, and Policy 2022 17:23
  18. The decades-long opioid epidemic and the more recent COVID-19 pandemic are two interacting events with significant public health impacts for people with opioid use disorder (OUD). Most published studies regard...

    Authors: Dennis P. Watson, Monte D. Staton, Christine E. Grella, Christy K. Scott and Michael L. Dennis
    Citation: Substance Abuse Treatment, Prevention, and Policy 2022 17:22
  19. There is growing evidence on the importance of a gendered understanding of recovery. Gender differences have been reported in relation to the nature and extent of substance use, pathways to and through substa...

    Authors: Valeria Abreu Minero, David Best, Lorna Brown, David Patton and Wouter Vanderplasschen
    Citation: Substance Abuse Treatment, Prevention, and Policy 2022 17:21
  20. Inner city patients have a higher illness burden and need for care, but experience more unmet care needs. Hospital Addiction Medicine Consult Teams (AMCTs) are a promising emerging intervention. The objective ...

    Authors: Ginetta Salvalaggio, Kathryn A. Dong, Elaine Hyshka, Christopher McCabe, Lara Nixon, Rhonda J. Rosychuk, Klaudia Dmitrienko, Judith Krajnak, Kelly Mrklas and T. Cameron Wild
    Citation: Substance Abuse Treatment, Prevention, and Policy 2022 17:20
  21. West Virginia has one of the highest rates of opioid overdose related deaths and is known as the epicenter of the opioid crisis in the United States. In an effort to reduce opioid-related harms, SB 273 was sig...

    Authors: Cara L. Sedney, Treah Haggerty, Patricia Dekeseredy, Divine Nwafor, Martina Angela Caretta, Henry H. Brownstein and Robin A. Pollini
    Citation: Substance Abuse Treatment, Prevention, and Policy 2022 17:19
  22. From a public health perspective, electronic nicotine delivery devices (ENDS) use may be beneficial for some populations (e.g., smokers who fully switch to ENDS) but detrimental for others (e.g., nonsmokers). ...

    Authors: Chineme Enyioha, Marcella H. Boynton, Leah M. Ranney, M. Justin Byron, Adam O. Goldstein and Christine E. Kistler
    Citation: Substance Abuse Treatment, Prevention, and Policy 2022 17:18
  23. As of 2021, 21 US states and territories allowed recreational cannabis use. Although previous research has identified an overall increase in prevalence of cannabis use after legalization, it has been less clea...

    Authors: Zachary Carlson, Steven Pham, Jackie El-Sokkary and Dorie E. Apollonio
    Citation: Substance Abuse Treatment, Prevention, and Policy 2022 17:17
  24. Timely data from official sources regarding the impact of the COVID-19 pandemic on people who use prescription and illegal opioids is lacking. We conducted a large-scale, natural language processing (NLP) anal...

    Authors: Abeed Sarker, Nisha Nataraj, Wesley Siu, Sabrina Li, Christopher M. Jones and Steven A. Sumner
    Citation: Substance Abuse Treatment, Prevention, and Policy 2022 17:16
  25. The coronavirus disease 2019 (COVID-19) pandemic has impacted people with substance use disorders (SUDs) worldwide. The aim of this study was to explore, changes in the number of SUD treatment episodes provide...

    Authors: Nadine Harker, Kim Johnson, Jodilee Erasmus and Bronwyn Myers
    Citation: Substance Abuse Treatment, Prevention, and Policy 2022 17:15
  26. Daily cannabis use is most strongly implicated in the cannabis-attributable burden of disease. In the context of the novel coronavirus disease (COVID-19) pandemic in Canada, we characterized trends in daily ca...

    Authors: Sameer Imtiaz, Samantha Wells, Jürgen Rehm, Christine M. Wickens, Hayley Hamilton, Yeshambel T. Nigatu, Damian Jankowicz and Tara Elton-Marshall
    Citation: Substance Abuse Treatment, Prevention, and Policy 2022 17:14
  27. During the scaling-up of a national Norwegian take-home naloxone (THN) program, data collection methods shifted from paper-based to electronic. The aim of this study was to explore staff preferences towards th...

    Authors: Øystein Bruun Ericson, Desiree Eide, Philipp Lobmaier and Thomas Clausen
    Citation: Substance Abuse Treatment, Prevention, and Policy 2022 17:13
  28. Cannabis use during methadone treatment may negatively impact treatment outcomes. The aim of this study was to determine the prevalence and pattern of cannabis use among patients attending a methadone treatmen...

    Authors: Elizabeth Wambui Ngarachu, Sarah Kanana Kiburi, Frederick R. Owiti and Rachel Kangethe
    Citation: Substance Abuse Treatment, Prevention, and Policy 2022 17:12
  29. One of the most important routes of HIV transmission is through injections of drugs, and this group, due to unawareness of their infection, causes the spread of HIV. The coexistence of other opportunistic infe...

    Authors: Negin Farhadian, Behzad Karami Matin, Vahid Farnia, Mohammad Hossein Zamanian, Farid Najafi and Maryam Farhadian
    Citation: Substance Abuse Treatment, Prevention, and Policy 2022 17:11
  30. In order to assist the State of Ohio in the United States in addressing the opioid epidemic, the Ohio Attorney General appointed experts in a variety of academic disciplines to the Scientific Committee on Opio...

    Authors: Myriam Shaw Ojeda, Aleda M. H. Chen, Tessa Miracle, Elizabeth Delaney, Caroline E. Freiermuth and Jon E. Sprague
    Citation: Substance Abuse Treatment, Prevention, and Policy 2022 17:10
  31. Age is a critical factor in substance use and related outcomes, with adolescence being a particularly sensitive period. Early initiation of substance use has been linked with higher risk for developing substan...

    Authors: Farihah Ali, Cayley Russell, Frishta Nafeh, Claudia Chaufan, Sameer Imtiaz, Jürgen Rehm, Adrienne Spafford and Tara Elton-Marshall
    Citation: Substance Abuse Treatment, Prevention, and Policy 2022 17:9
  32. Patients in opioid substitution treatment (OST) have poorer health than the general population. Thus, they do not seek somatic health care to the extent that is medically motivated. Barriers hindering patients...

    Authors: Katja Troberg, Karin Lundqvist, Helena Hansson, Anders Håkansson and Disa Dahlman
    Citation: Substance Abuse Treatment, Prevention, and Policy 2022 17:8
  33. To examine whether changes in density of neighborhood alcohol outlets affected changes in alcohol consumption 1-year after regulatory changes increased alcohol availability.

    Authors: Amy H. Auchincloss, Saima Niamatullah, Maura Adams, Steven J. Melly, Jingjing Li and Mariana Lazo
    Citation: Substance Abuse Treatment, Prevention, and Policy 2022 17:7
  34. In 2017, the United States Comprehensive Addiction and Recovery Act (CARA) expanded authorization to prescribe buprenorphine for opioid use disorder (OUD) to nurse practitioners (NPs). Compared to physicians, ...

    Authors: Tracy A. Klein, Daniel Hartung and Sheila Markwardt
    Citation: Substance Abuse Treatment, Prevention, and Policy 2022 17:5
  35. In response to COVID-19, the city of Chicago issued stay-at-home orders, which began on March 20, 2020, and restrictions meant to “flatten the curve” remained in effect until June 2, 2020. On June 3, 2020, Chi...

    Authors: Raymond L. Moody, Yen-Tyng Chen, John A. Schneider, Justin Knox, Liadh Timmins, Hillary Hanson, Kangkana Koli, Mainza Durrell, Jessica Dehlin, Rebecca Eavou, Silvia S. Martins and Dustin T. Duncan
    Citation: Substance Abuse Treatment, Prevention, and Policy 2022 17:4
  36. There is a marked paucity of published evidence on the extent and nature of substance use disorders in the State of Qatar. This is mirrored by a dearth of information on the policy for the treatment of substan...

    Authors: Majid Alabdulla, Nimesh Samarasinghe, Iain Tulley and Shuja Reagu
    Citation: Substance Abuse Treatment, Prevention, and Policy 2022 17:3
  37. To tackle the long-standing opioid misuse problem, Myanmar introduced the methadone maintenance treatment (MMT) program in 2006, starting with 260 clients. Since then, the program has been expanded across diff...

    Authors: Sun Tun, Balasingam Vicknasingam, Darshan Singh and Nyunt Wai
    Citation: Substance Abuse Treatment, Prevention, and Policy 2022 17:2

    The Correction to this article has been published in Substance Abuse Treatment, Prevention, and Policy 2022 17:6

  38. As Colorado ranked among the top nationally in non-medical use of opioids, a pilot medication for opioid use disorder (MOUD) program was developed to increase the number of NPs and PAs providing MOUD in order ...

    Authors: Claudia R. Amura, Tanya R. Sorrell, Mary Weber, Andrea Alvarez, Nancy Beste, Ursula Hollins and Paul F. Cook
    Citation: Substance Abuse Treatment, Prevention, and Policy 2022 17:1
  39. Neonatal abstinence syndrome (NAS) incidence has significantly increased in the US in recent years. It is therefore important to develop effective intervention protocols that mitigate the long-term consequence...

    Authors: Diana López-Soto and Paul M. Griffin
    Citation: Substance Abuse Treatment, Prevention, and Policy 2021 16:91
  40. Many young people in Korea today experience deprivation in various areas of life. The social determinants of health approach maintains that social factors play an important role in an individual’s physical and...

    Authors: Soo Bi Lee and Sulki Chung
    Citation: Substance Abuse Treatment, Prevention, and Policy 2021 16:90
  41. This study measured emergency department (ED) use and hospitalization for medical reasons among patients with substance-related disorders (SRD), comparing four subgroups: cannabis-related disorders, drug-relat...

    Authors: Bahram Armoon, Guy Grenier, Zhirong Cao, Christophe Huỳnh and Marie-Josée Fleury
    Citation: Substance Abuse Treatment, Prevention, and Policy 2021 16:89
  42. This study examined the perceived difficulty of getting help with substance use among sexual and gender minorities who have sex with men (SGMSM) who use methamphetamine during the early COVID-19 period.

    Authors: Kiffer Card, Madison McGuire, Jordan Bond-Gorr, Tribesty Nguyen, Gordon A. Wells, Karyn Fulcher, Graham Berlin, Nicole Pal, Mark Hull and Nathan J. Lachowsky
    Citation: Substance Abuse Treatment, Prevention, and Policy 2021 16:88
  43. There are preliminary indications that the trajectory of drug overdose-related deaths in North America has been exacerbated due to the novel coronavirus disease pandemic (COVID-19). As such, the impact of COVI...

    Authors: Sameer Imtiaz, Frishta Nafeh, Cayley Russell, Farihah Ali, Tara Elton-Marshall and Jürgen Rehm
    Citation: Substance Abuse Treatment, Prevention, and Policy 2021 16:87
  44. In sub-Saharan Africa, there is paucity of research on substance use patterns among young people living with HIV (YLWH). To address the gap, we sought to: i) determine the prevalence of substance use, specific...

    Authors: Moses K. Nyongesa, Paul Mwangi, Michael Kinuthia, Amin S. Hassan, Hans M. Koot, Pim Cuijpers, Charles R. J. C. Newton and Amina Abubakar
    Citation: Substance Abuse Treatment, Prevention, and Policy 2021 16:86
  45. E-cigarettes are increasing in popularity, particularly among young adults. With public health organisations contesting the possible benefits of e-cigarettes, research is required to explore young adults’ use ...

    Authors: Ananth Ranjit, Grace McCutchan, Katherine Brain and Ria Poole
    Citation: Substance Abuse Treatment, Prevention, and Policy 2021 16:85
  46. Alcohol use during pregnancy has been associated with several birth defects and developmental disabilities generally known as Fetal Alcohol Spectrum Disorders (FASD). Contextual in-depth understanding on why w...

    Authors: Apophia Agiresaasi, Nazarius Mbona Tumwesigye, Elizabeth Nabiwemba, Juliet Kiguli, Gakenia Wamuyu Maina and Goretti Nassanga
    Citation: Substance Abuse Treatment, Prevention, and Policy 2021 16:84
  47. The use of alcohol and illicit drugs during adolescence can lead to serious short- and long-term health related consequences. Despite a global trend of decreased substance use, in particular alcohol, among ado...

    Authors: Pia Kvillemo, Linda Hiltunen, Youstina Demetry, Anna-Karin Carlander, Tim Hansson, Johanna Gripenberg, Tobias H. Elgán, Kim Einhorn and Charlotte Skoglund
    Citation: Substance Abuse Treatment, Prevention, and Policy 2021 16:83
  48. Substance using often cause a wide range of social, health, and psychological problems. This study aimed to develop and validate a questionnaire of barriers of treatment in substance users.

    Authors: Hamid Tavakoli Ghouchani, Hossein Lashkardoost, Hassan Saadati, Seyed Kaveh Hojjat, Faezeh Kaviyani, Kazem Razaghi, Dordane Asghari and Nazanin Gholizadeh
    Citation: Substance Abuse Treatment, Prevention, and Policy 2021 16:82

Annual Journal Metrics